HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antigen-specific CD8(+) T cells and protective immunity to tuberculosis.

Abstract
The continuing HIV/AIDS epidemic and the spread of multi-drug resistant Mycobacterium tuberculosis has led to the perpetuation of the worldwide tuberculosis epidemic. While M. bovis BCG is widely used as a vaccine, it lacks efficacy in preventing pulmonary tuberculosis in adults [1]. To combat this ongoing scourge, vaccine development for tuberculosis is a global priority. Most infected individuals develop long-lived protective immunity, which controls and contains M. tuberculosis in a T cell-dependent manner. An effective T cells response determines whether the infection resolves or develops into clinically evident disease. Consequently, there is great interest in determining which T cells subsets mediate anti-mycobacterial immunity, delineating their effector functions, and evaluating whether vaccination can elicit these T cells subsets and induce protective immunity. CD4(+) T cells are critical for resistance to M. tuberculosis in both humans and rodent models. CD4(+) T cells are required to control the initial infection as well as to prevent recrudescence in both humans and mice [2]. While it is generally accepted that class II MHC-restricted CD4(+) T cells are essential for immunity to tuberculosis, M. tuberculosis infection elicits CD8(+) T cells responses in both people and in experimental animals. CD8(+) T cells are also recruited to the lung during M. tuberculosis infection and are found in the granulomas of infected people. Thus, how CD8(+) T cells contribute to overall immunity to tuberculosis and whether antigens recognized by CD8(+) T cells would enhance the efficacy of vaccine strategies continue to be important questions.
AuthorsSamuel M Behar
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 783 Pg. 141-63 ( 2013) ISSN: 0065-2598 [Print] United States
PMID23468108 (Publication Type: Journal Article, Review)
Chemical References
  • Antigens, Bacterial
  • Bacterial Proteins
  • CFP-10 protein, Mycobacterium tuberculosis
  • ESAT-6 protein, Mycobacterium tuberculosis
  • Epitopes, T-Lymphocyte
  • Immunodominant Epitopes
  • Tuberculosis Vaccines
Topics
  • Animals
  • Antigens, Bacterial (immunology)
  • Bacterial Proteins (immunology)
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cross-Priming
  • Dendritic Cells (immunology)
  • Endosomes (immunology, microbiology)
  • Epitopes, T-Lymphocyte (immunology)
  • Humans
  • Immunity, Cellular
  • Immunodominant Epitopes (immunology)
  • Macrophages (microbiology)
  • Mice
  • Mice, Mutant Strains
  • Mycobacterium tuberculosis (immunology)
  • Phagosomes (immunology, microbiology)
  • T-Cell Antigen Receptor Specificity
  • Tuberculosis (epidemiology, immunology, prevention & control)
  • Tuberculosis Vaccines (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: